Michael Sen

Michael Sen has been Chairman of the Management Board of Fresenius SE, a DAX 40 healthcare company headquartered in Bad Homburg v. d. Höhe, since October 1, 2022. He also serves as Chairman of the Supervisory Board of Fresenius Medical Care. This top executive with international experience possesses extensive expertise in the transformation and strategic realignment of global companies. In fiscal year 2025, Fresenius generated revenue of 22.6 billion euros with approximately 178,000 employees. Through the #FutureFresenius strategy program, Michael Sen is driving the company’s positioning in future-oriented fields such as cell and gene therapy, biosimilars, and artificial intelligence.